Severe Dilated Cardiomyopathy in a Patient With Myotonic Dystrophy Type 2 and Homozygous Repeat Expansion in ZNF9

Congestive Heart Failure

Volumn 18, Issue 3, 2012, Pages 183-186

  Lee, Teresa M ^a   Maurer, Mathew S ^a   Karbassi, Izabela ^b   Braastad, Corey ^b   Batish, Sat D ^b   Chung, Wendy K ^a  

^a Department of Medicine   (United States)

^b ATHENA DIAGNOSTICS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; DIGOXIN; FUROSEMIDE; ISOSORBIDE MONONITRATE; LISINOPRIL; METOPROLOL; MILRINONE; ROSUVASTATIN; WARFARIN;

ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOMYOPATHY; CAUSE OF DEATH; CONGESTIVE CARDIOMYOPATHY; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY DISEASE; DIPLOPIA; DRUG WITHDRAWAL; DYSPHAGIA; DYSPNEA; EDEMA; ELECTROCARDIOGRAPHY; ELECTROMYOGRAPHY; FAMILY HISTORY; FATIGUE; FEMALE; FIBROELASTOMA; HEART ATRIUM FIBRILLATION; HEART ATRIUM PRESSURE; HEART FAILURE; HEART INDEX; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART OUTPUT; HEART RIGHT BUNDLE BRANCH BLOCK; HEART RIGHT VENTRICLE PRESSURE; HEART VALVE REGURGITATION; HOMOZYGOSITY; HUMAN; HUMAN TISSUE; MITRAL VALVE REPAIR; MUSCLE BIOPSY; MUSCLE WEAKNESS; MYOTONIA; MYOTONIC DYSTROPHY; NEUROLOGIC EXAMINATION; PEDIGREE ANALYSIS; PRIORITY JOURNAL; QT PROLONGATION; RHEUMATIC HEART DISEASE; STENT; THORAX PAIN; TRANSTHORACIC ECHOCARDIOGRAPHY; TRICUSPID VALVE REPAIR;

AGED; CARDIOMYOPATHY, DILATED; DNA REPEAT EXPANSION; FEMALE; HOMOZYGOTE; HUMANS; MYOTONIC DISORDERS; RNA-BINDING PROTEINS;

EID: 84861183915     PISSN: 15275299     EISSN: 17517133     Source Type: Journal    
DOI: 10.1111/j.1751-7133.2011.00265.x     Document Type: Article

References (12)

1. Finsterer J, Stöllberger C. Cardiac involvement in primary myopathies. Cardiology. 2000;94:1-11.
2. Turner C, Hilton-Jones D. The myotonic dystrophies: diagnosis and management. J Neurol Neurosurg Psychiatry. 2010;81:358-367.
3. Day JW, Roelofs R, Leroy B, et al. Clinical and genetic characteristics of a five-generation family with a novel form of myotonic dystrophy (DM2). Neuromuscul Disord. 1999;9:19-27.
4. von Zur Mühlen F, Klass C, Kreuzer H, et al. Cardiac involvement in proximal myotonic myopathy. Heart. 1998;79:619-621.
5. Wahbi K, Meune C, Bassez G, et al. Left ventricular non-compaction in a patient with myotonic dystrophy type 2. Neuromuscul Disord. 2008;18:331-333.
6. Lee JE, Cooper TA. Pathogenic mechanisms of myotonic dystrophy. Biochem Soc Trans. 2009;37:1281-1286.
7. Schoser BG, Kress W, Walter MC, et al. Homozygosity for CCTG mutation in myotonic dystrophy type 2. Brain. 2004;127:1868-1877.
8. Schneider-Gold C, Beer M, Köstler H, et al. Cardiac and skeletal muscle involvement in myotonic dystrophy type 2 (DM2): a quantitative 31P-MRS and MRI study. Muscle Nerve. 2004;30:636-644.
9. Verhaert D, Richards K, Rafael-Fortney JA, Raman SV. Cardiac involvement in patients with muscular dystrophies: magnetic resonance imaging phenotype and genotypic considerations. Circ Cardiovasc Imaging. 2011;4:67-76.
10. Breton R, Mathieu J. Usefulness of clinical and electrocardiographic data for predicting adverse cardiac events in patients with myotonic dystrophy. Can J Cardiol. 2009;25:23-27.
11. Wahbi K, Meune C, Bécane HM, et al. Left ventricular dysfunction and cardiac arrhythmias are frequent in type 2 myotonic dystrophy: a case control study. Neuromuscul Disord. 2009;19:468-472.
12. Schoser BG, Ricker K, Schneider-Gold C, et al. Sudden cardiac death in myotonic dystrophy type 2. Neurology. 2004;63:2402-2404.